Teva Targeted Over Alleged US Nuvigil-EpiPen Conspiracy

Follows Combined $600m Settlements Signed By Mylan, Pfizer

Teva secretly conspired with Mylan and Pfizer to delay generic versions of one another’s lucrative brands by several years, a newly-filed US antitrust lawsuit naming the Israeli firm alleges.

Antitrust law - Image
Teva was sued over its ANDA in 2009 • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin